Myomo, Inc. (NYSEAMERICAN:MYO – Get Free Report) insider Micah Mitchell sold 48,000 shares of the company’s stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $5.16, for a total transaction of $247,680.00. Following the completion of the sale, the insider now owns 140,572 shares in the company, valued at approximately $725,351.52. This trade represents a 25.45 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Myomo Stock Performance
Shares of Myomo stock opened at $5.19 on Friday. The company has a market cap of $157.00 million, a P/E ratio of -22.57 and a beta of 1.68. Myomo, Inc. has a twelve month low of $2.51 and a twelve month high of $7.17.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Barclays PLC bought a new position in Myomo in the third quarter worth approximately $36,000. BNP Paribas Financial Markets bought a new position in Myomo in the fourth quarter worth approximately $64,000. Jane Street Group LLC bought a new position in Myomo in the third quarter worth approximately $65,000. Walleye Capital LLC bought a new position in Myomo in the fourth quarter worth approximately $66,000. Finally, Squarepoint Ops LLC bought a new position in Myomo in the fourth quarter worth approximately $74,000. Institutional investors own 44.99% of the company’s stock.
Analyst Upgrades and Downgrades
Get Our Latest Research Report on Myomo
Myomo Company Profile
Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.
Recommended Stories
- Five stocks we like better than Myomo
- What is the Nikkei 225 index?
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- How to Short Nasdaq: An Easy-to-Follow Guide
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Myomo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Myomo and related companies with MarketBeat.com's FREE daily email newsletter.